NCT04525157View on ClinicalTrials.gov

Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 6, 2014

Primary Completion Date

February 2, 2016

Study Completion Date

June 6, 2016

Conditions
Vitiligo
Interventions
DRUG

Afamelanotide

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Clinuvel Pharmaceuticals Limited

INDUSTRY